国药股份

600511 SSE 证监会行业分类 F51批发业

Key Metrics

Market Cap

22.2B ($3.2B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

52.5B

Net Income

2.1B

Gross Margin

N/A

Op. Margin

5.0%

Net Margin

4.0%

ROE

10.3%

ROA

5.7%

D/E

0.81

Dividend Yield

N/A

EPS

2.65

Current Ratio

2.08

Price History

Company Info

Industry	F51批发业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2025

Business Overview

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 国药股份

Ticker	600511
Exchange	SSE
Sector	证监会行业分类
Industry	F51批发业